Pharmacokinetic study of colistimethate sodium
Phase 1 other active
Quick answer
Pharmacokinetic study of colistimethate sodium for serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options is a Phase 1 program (other) at Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
- Indication
- serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options
- Phase
- Phase 1
- Modality
- other
- Status
- active